Advertisement
Letter to the Editor| Volume 135, P8-10, August 2020

Download started.

Ok

Comment on “The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region” and reflections from the Italian Association of Oncology Nurses

      To the editor,
      We thank Trapani et al. [
      • Trapani D.
      • Marra A.
      • Curigliano G.
      The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region.
      ] for their contribution aimed at sharing the experience of the reorganisation of cancer care to respond to novel coronavirus disease (COVID-19) in the Lombardy Region (Italy). Trapani et al. [
      • Trapani D.
      • Marra A.
      • Curigliano G.
      The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region.
      ] described the Italian cancer mortality and an interim analysis of nine patients with cancer and COVID-19, mainly managed using home-based management. We agree with the authors in identifying the continuum of care as the key to success in COVID-19 and cancer management, as well as the strong need of keeping the connection between health needs and cancer management. Forasmuch, in accordance with what is highlighted by Trapani et al. [
      • Trapani D.
      • Marra A.
      • Curigliano G.
      The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region.
      ], the Italian Association of Oncology Nurses (AIIAO) is mapping the situation of the self-isolated patients with cancer at home in the context of the COVID-19.
      On 9th March 2020, the Italian authority locked down the country to contain the spread of COVID-19. Specific recommendations were provided to people living with cancer, who were encouraged to stay at home in self-isolation, especially elderly and immunocompromised patients, because they were considered at an increased risk of COVID-19 infection and severe events [
      • Richardson S.
      • Hirsch J.S.
      • Narasimhan M.
      • Crawford J.M.
      • McGinn T.
      • Davidson K.W.
      • et al.
      Presenting Characteristics, Comorbidities, and Outcomes among 5700 patients Hospitalized with COVID-19 in the New York City Area.
      ]. Moreover, non-urgent visits were postponed, and several specialist cancer wards were converted into isolation units for patients with COVID-19 infection or closed because of staff shortage [
      • Burki T.K.
      Cancer care in the time of COVID-19.
      ]. Furthermore, patients with cancer are in urgent need of blood monitoring, chemotherapy, scans, transplants and surgery, which, if delayed indefinitely, could mean loss of the window to treat. In this context, we started an online survey to describe the situation of the self-isolated patients with cancer at home in the context of the COVID-19. Thus far, we have performed an interim analysis for data collected between 29th March and 3rd May 2020. Accordingly, 195 patients completed the survey. They were mainly women (n = 148, 75.9%), with a mean age of 50.3 (standard deviation, SD = 11.2, range = 25–78) years and a high level of education (university or postgraduate = 66, 34%). The majority of patients had haematological malignancies (n = 100, 51.3%), followed by patients with breast cancer (n = 51, 26.2%) and other solid tumours (n = 44, 22.6%). The majority were from the north of Italy (38.9%), 34.7% from the south and 26.4% from central regions. Table 1 shows patients' beliefs, behaviour and access to care.
      Table 1Participants' beliefs, behaviour and access to care (n = 195).
      Investigated topicsn%
      Leaving the house
       Never4121.1
       Rarely11559.3
       Sometimes (2–3 times per week)2311.9
       Every day157.7
      Reason for leaving the house
      Multi response variable.
       Health9649.7
       Job168.3
       Supermarket9750.3
       Walking2513.0
       Never going out2814.5
      COVID-19 risk infection
       I believe I am at higher risk10553.8
       I believe I am not at higher risk9046.2
      I believe I will suffer from severe consequences in case of infection due to my cancer
       Very much/completely9950.8
       Quite a bit4623.6
       A little/not at all5025.6
      Behaviours to lower infection risk
      Multi response variable.
       Hand washing18095.2
       Social distance15481.5
       Face mask without valve13672.0
       Face mask with valve4624.3
       Gloves10555.6
       Disinfecting surfaces/cloths/groceries5629.6
      Changes in relating with family members
      Multi response variable.
       Nothing changed10756.0
       No kisses and hugs6131.9
       Social distance2312.0
       Separate rooms136.8
       Other136.8
      Using remedies to prevent COVID-19 infection
       Yes5729.2
       No13870.8
      Health status under control
       Yes13771.0
       No5629.0
      Fear of going to the hospital
       Very much/completely7237.3
       Quite a bit4020.7
       A little6533.7
       Not at all168.3
      Frequency of going to the hospital
       Not going at all7337.8
       Diminished frequency4623.8
       Same frequency as usual6835.2
       Other52.6
      COVID-19, novel coronavirus disease.
      a Multi response variable.
      Overall, an important number of patients reported that their cancer disease was not under control (29%). This is especially alarming given that three patients of four experienced difficult access to safe cancer care 62%), especially regarding follow-up visits, which were often postponed. Patients with cancer not only were considered at higher risk for COVID-19 infection but also had to pay the price for an emergent imperative to reduce cancer care activity associated with several factors [
      • Coles C.E.
      • Aristei C.
      • Bliss J.
      • Boersma L.
      • Brunt A.M.
      • Chatterjee S.
      • et al.
      International Guidelines on Radiation Therapy for breast cancer during the COVID-19 Pandemic.
      ]. These included the need to respect imperative social distancing, the lack of beds in intensive care units, the increased workload [
      • Lucchini A.
      • Giani M.
      • Elli S.
      • Villa S.
      • Rona R.
      • Foti G.
      Nursing Activities Score is increased in COVID-19 patients.
      ], the reduction of the oncology workforce caused by the reallocation of healthcare providers into COVID-19 units or quarantine at home and shortages of personal protective equipment [
      • Lambertini M.
      • Toss A.
      • Passaro A.
      • Criscitiello C.
      • Cremolini C.
      • Cardone C.
      • et al.
      Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: Young oncologists' perspective.
      ].
      Another important factor to consider is that patients with cancer were afraid to go to the hospital even when they needed and sometimes decided to cancel their appointments. Stay-at-home campaigns may have reinforced people's awareness about the importance of self-isolation as an effective preventive measure for reducing virus spread and the risk of infection. However, they may also have increased the perception of hospitals as places where people get infected. This could have added further uncertainty to patients whose illness anxiety has already been negatively influencing their mental well-being [
      • Guan T.
      • Santacroce S.J.
      • Chen D.G.
      • Song L.
      Illness uncertainty, coping, and quality of life among patients with prostate cancer.
      ]. Moreover, 44% of participants reported the fear that their cancer disease would be regarded as of secondary importance. In light of this consideration, health professionals should help patients in prioritising their own health needs [
      • Cinar P.
      • Kubal T.
      • Freifeld A.
      • Mishra A.
      • Shulman L.
      • Bachman J.
      • et al.
      Safety at the time of the COVID-19 Pandemic: How to Keep our oncology patients and healthcare workers safe.
      ].
      Participants reported to take several measures to reduce their infection risk, including hand washing, use of facemasks and gloves. Because patients with cancer usually feel more vulnerable than the general population and are more used to hypervigilance and protective measures, it is not surprising that they adopted preventive behaviours promptly. However, only 54% believed to be at higher risk for COVID-19 infection and 51% for complications. The scarcity of information about who was at higher risk and the reassuring attitudes of many clinicians may have contributed to this perception. Besides, participants had clear in mind the importance of maintaining a positive attitude in light of difficult circumstances. In fact, patients with cancer could be considered experts in adapting to the new normal.
      Among spontaneous preventive behaviours, about one-third of participants reported taking supplements as remedies to reduce the likelihood of being infected. These included vitamins C and D, which were not specifically recommended by health professionals due to the lack of evidence from ongoing clinical trials [
      • Carr A.C.
      A new clinical trial to test high-dose vitamin C in patients with COVID-19.
      ]. On the one hand, this is not surprising as patients feel that they should be doing something on their own and are thereby continuously searching for supplements able to protect their body's cells and tissues from oxidative damage and dysfunction while supporting healthy immune function. On the other hand, self-care strategies such as a well-balanced diet, regular exercise and good relationships seem underestimated for their potential to support the immune response, without interfering with the actual cancer treatment.
      In conclusion, we would like to stress again what was expressed by Trapani et al. [
      • Trapani D.
      • Marra A.
      • Curigliano G.
      The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region.
      ]: ‘Understanding and implementing the scopes and goals of the global responses and enforcing community flexibility, and not merely advocating for a patient-centred approach. The resilience, capacities, skills and resources of the context must be recognized, and these must be built on to deliver protection and solutions while supporting the community's own goal. The ultimate goal now is to end COVID-19 as one global community’. To succeed in COVID-19 and cancer management, the understanding of the unanswered health needs of patients with cancer is pivotal a multi-professional call to action to build a sound strategy in every context is needed.

      Funding

      This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

      Conflict of interest statement

      Authors have no potential conflicts of interest to disclose.

      Acknowledgements

      The authors would like to thank the patient participants and, in particular, Sandro Muscolino, Donatella Giagnori and Antonella Barone for their precious suggestions for the survey development. The authors also acknowledge the support of Serafina Biagioli, PsyD, in survey revision.

      References

        • Trapani D.
        • Marra A.
        • Curigliano G.
        The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region.
        Eur J Canc. 2020; 132: 199-206https://doi.org/10.1016/j.ejca.2020.04.017
        • Richardson S.
        • Hirsch J.S.
        • Narasimhan M.
        • Crawford J.M.
        • McGinn T.
        • Davidson K.W.
        • et al.
        Presenting Characteristics, Comorbidities, and Outcomes among 5700 patients Hospitalized with COVID-19 in the New York City Area.
        JAMA. 2020; https://doi.org/10.1001/jama.2020.6775
        • Burki T.K.
        Cancer care in the time of COVID-19.
        Lancet Oncol. 2020; https://doi.org/10.1016/S1470-2045(20)30201-1
        • Coles C.E.
        • Aristei C.
        • Bliss J.
        • Boersma L.
        • Brunt A.M.
        • Chatterjee S.
        • et al.
        International Guidelines on Radiation Therapy for breast cancer during the COVID-19 Pandemic.
        Clin Oncol. 2020; 32: 279-281https://doi.org/10.1016/j.clon.2020.03.006
        • Lucchini A.
        • Giani M.
        • Elli S.
        • Villa S.
        • Rona R.
        • Foti G.
        Nursing Activities Score is increased in COVID-19 patients.
        Intensive Crit Care Nurs. 2020; : 102876https://doi.org/10.1016/j.iccn.2020.102876
        • Lambertini M.
        • Toss A.
        • Passaro A.
        • Criscitiello C.
        • Cremolini C.
        • Cardone C.
        • et al.
        Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: Young oncologists' perspective.
        ESMO Open. 2020; : 5https://doi.org/10.1136/esmoopen-2020-000759
        • Guan T.
        • Santacroce S.J.
        • Chen D.G.
        • Song L.
        Illness uncertainty, coping, and quality of life among patients with prostate cancer.
        Psycho Oncol. 2020; https://doi.org/10.1002/pon.5372
        • Cinar P.
        • Kubal T.
        • Freifeld A.
        • Mishra A.
        • Shulman L.
        • Bachman J.
        • et al.
        Safety at the time of the COVID-19 Pandemic: How to Keep our oncology patients and healthcare workers safe.
        J Natl Compr Canc Netw. 2020; : 1-6https://doi.org/10.6004/jnccn.2020.7572
        • Carr A.C.
        A new clinical trial to test high-dose vitamin C in patients with COVID-19.
        Crit Care. 2020; 24: 133https://doi.org/10.1186/s13054-020-02851-4

      Linked Article

      • The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region
        European Journal of CancerVol. 132
        • Preview
          The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease (coronavirus disease 2019 [COVID-19]) has spread rapidly to a pandemic proportion, increasing the demands on health systems for the containment and management of COVID-19. Cancer has been reported as a major risk factor for adverse outcomes of and death from COVID-19. We extracted data from the World Health Organization's progress reports and from the Italian Council of Medicine. In addition, we retrieved clinical data on patients with cancer and with confirmed COVID-19 in our institution.
        • Full-Text
        • PDF